Jazz pharmaceuticals plc (JAZZ)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities
Net income (loss)

-157,833

73,992

102,276

261,898

85,201

159,470

149,316

92,321

45,991

232,207

63,526

105,604

86,511

116,689

89,828

114,502

75,812

82,761

87,960

88,113

70,700

81,611

25,768

43,586

-93,639

55,293

75,409

42,185

43,425

200,551

33,209

27,145

27,681

37,473

32,482

33,202

21,827

Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Intangible asset amortization

62,847

173,490

62,863

61,576

56,885

46,543

46,989

54,959

53,007

52,901

47,313

26,186

25,665

26,162

26,453

26,737

22,642

23,690

26,127

23,668

24,677

31,977

30,630

32,795

31,182

20,524

19,564

19,399

19,555

21,908

21,750

15,751

13,513

1,862

1,862

1,862

1,862

Share-based compensation

28,654

25,937

28,785

28,289

27,552

26,723

25,103

26,312

24,303

27,321

27,126

27,260

25,193

24,281

24,874

25,433

24,183

24,317

23,114

23,300

20,819

19,020

18,251

18,552

13,815

12,412

11,876

11,506

8,757

7,855

6,612

5,258

3,281

10,946

3,195

3,415

3,148

Impairment charge

136,139

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

4,527

4,457

3,991

3,355

3,539

3,870

3,906

3,735

3,722

3,801

3,065

3,093

3,130

3,621

3,121

2,517

2,527

2,751

2,548

2,363

2,232

2,060

1,868

1,860

1,309

983

895

595

575

518

374

229

186

111

79

85

104

Acquired in-process research and development

202,250

0

51,775

2,200

56,000

0

0

0

0

-

-

-

-

0

15,000

0

8,750

0

0

0

0

626

75,000

0

127,000

0

988

0

4,000

-

-

-

-

-

-

-

-

Loss on disposal of assets

-73

-13

-1

-4

-3

-3

-537

141

-256

-113

97

-375

-82

-44

34

0

-37

-55

-71

-38

-8

-24

0

2

-2

1

-7

0

-40

-17

-7

-139

0

-

-

-

-

Acquisition accounting inventory fair value step-up adjustments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

2,455

8,022

683

512

1,086

1,545

2,117

11,442

4,011

2,369

-

-

-

-

Excess tax benefit from share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-320

-10,635

10,635

-

3,283

-4,985

5,777

-82

82

-889

889

5,519

-1,972

4,324

1,914

-

-

-

-

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,300

-5,000

-3,400

-4,500

1,400

-900

-200

0

-

-

-

-

Deferred tax benefit

-63,976

-68,675

-16,588

-134,294

-17,053

-44,157

-12,430

-16,921

-15,307

-172,232

-23,403

-14,956

-15,000

-11,890

-19,161

-4,370

-5,742

-42,990

-8,495

-7,612

-9,261

-13,008

-17,648

-14,220

-4,378

7,865

-8,898

-5,190

-3,874

-105,094

-8,768

0

0

-

-

-

-

Provision for losses on accounts receivable and inventory

2,620

2,821

1,444

1,875

528

-6

2,064

2,080

590

365

277

600

948

445

76

790

898

41

3,411

184

426

-380

948

1,112

813

688

522

1,094

142

1,958

2,679

-26

43

-

-

-

-

Amortization of debt discount and deferred financing costs

12,000

11,981

11,831

11,451

11,133

11,291

11,165

10,887

10,617

10,792

7,855

5,764

5,615

5,715

5,642

5,414

5,362

5,390

5,300

6,032

6,016

-

-

-

-

-

-

-

-

-

-

-

42

-

-

-

-

Other non-cash transactions

-1,902

-386

1,890

1,809

738

2,471

4,026

5,030

-16,026

159

-6,480

-6,595

-1,405

5,201

-493

612

-1,579

1,353

-276

-1,274

5,384

4,604

10,289

-1,039

-1,868

2,748

-1,184

-1,276

-1,975

-

-

-

-

0

0

-188

-206

Changes in assets and liabilities:
Accounts receivable

-37,861

88,019

-43,267

-9,386

56,960

-15,386

1,162

-2,235

56,591

-34,551

19,235

-5,445

8,483

-2,671

6,116

8,356

13,802

14,180

2,182

3,710

4,769

4,351

28,801

5,875

16,014

11,197

-1,366

20,104

18,911

-13,049

10,346

-1,367

8,794

2,946

6,429

3,616

-698

Inventories

10,235

9,762

4,466

9,874

8,688

10,929

-1,355

5,626

3,312

1,535

1,253

1,621

4,258

2,907

-933

8,743

6,307

-9,866

1,746

7

1,842

-2,554

6,882

231

3,071

5,071

-2,659

7,335

-1,231

18

-926

-890

101

-591

-296

-302

-50

Prepaid expenses and other current assets

17,843

2,792

6,929

14,941

988

292

-12,257

1,734

3,534

16,284

9,720

-9,767

10,637

7,188

-1,823

9,104

1,231

-9,018

-8,378

-1,994

15,670

-7,674

-3,326

3,421

-4,357

2,571

-3,372

8,400

6,272

9,248

-1,547

3,173

2,217

-117

-769

978

842

Other non-current assets

-323

17,081

-1,557

-268

-426

76

2,011

-755

-1,012

-1,944

-442

97

2,170

30

-544

351

-104

-4,982

2,897

3,380

3,278

-2,715

2,410

1,820

1,545

885

804

1,618

999

1,194

1,943

56

298

-

-

-

-

Operating lease assets

-3,195

-3,229

-3,520

-5,291

-2,108

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets and liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-56

5

Accounts payable

19,604

-24,334

43,200

-15,650

1,554

6,924

2,745

-15,765

23,136

-5,916

783

-518

5,865

4,649

-10,512

-4,440

10,664

-7,106

2,697

-1,174

3,303

-4,101

-2,310

-40,134

8,579

-1,581

1,963

-11,451

16,158

-4,743

-13,906

6,714

4,649

-3,334

3,798

1,017

599

Accrued liabilities

-12,198

31,804

21,662

-55,301

-3,730

6,134

4,966

12,624

47,484

17,005

9,489

-17,329

-15,743

19,781

-4,058

2,972

-6,706

-1,656

22,777

-650

-17,485

1,529

20,289

-1,748

927

13,155

9,311

-5,089

-2,660

4,384

-26,583

17,310

-6,539

-1,051

9,121

3,439

-298

Income taxes payable

20,829

-32,757

13,763

-10,676

39,726

-5,736

-10,714

-17,468

14,183

7,836

6,008

-28,266

30,753

-361

-75

-22,360

25,758

-15,264

2,496

-23,666

30,163

-10,369

13,549

-303

5,757

-19,898

2,812

-20,501

-1,397

11,201

22,571

5,568

0

-

-

-

-

Deferred revenue

-1,180

-1,180

-1,180

-1,180

-1,874

-1,874

-1,874

-1,874

-1,875

-2,154

-2,157

-2,170

27,490

-633

-206

-210

-266

123

-277

-97

-285

-285

-361

-284

-273

-285

-284

-285

-207

-1,157

-298

535

-285

-284

-513

-479

3

Contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-14,900

0

0

0

0

-

-

-

-

-

-

-

-

Other non-current liabilities

7,316

7,195

-17,811

7,404

6,773

7,293

-6,711

6,304

7,651

6,003

-2,602

7,359

8,174

4,847

3,765

7,195

7,392

8,093

5,198

6,451

6,820

4,814

4,449

3,772

4,689

4,695

3,416

3,513

3,196

2,652

536

-836

-1

-

-

-

-

Operating lease liabilities, less current portion

-3,906

-2,907

-3,568

-425

856

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Liability under government settlement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-7,320

95

95

-1,072

-2,904

Net cash provided by operating activities

272,969

87,798

337,503

148,847

202,253

218,096

221,475

191,974

167,359

204,559

188,897

135,091

164,540

180,695

133,028

127,014

151,654

119,741

175,076

140,571

96,555

134,262

129,697

74,924

68,723

79,034

130,788

8,719

69,890

104,345

44,143

76,969

24,295

43,659

46,053

37,436

24,448

Investing activities
Proceeds from maturity of investments

345,000

165,000

190,000

285,000

345,000

290,000

180,000

190,000

195,000

80,000

50,000

40,000

60,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property, plant and equipment

4,830

7,137

11,087

13,963

7,948

5,149

3,940

4,132

7,149

8,878

8,347

8,151

3,574

1,277

2,382

3,556

2,472

3,367

5,159

13,022

14,410

13,548

8,139

11,133

3,527

3,102

2,164

3,567

1,143

983

2,499

2,209

285

756

362

95

66

Acquired in-process research and development

202,250

0

3,500

2,200

56,000

0

0

0

0

-

-

-

-

0

15,000

0

8,750

0

0

0

0

626

75,000

2,000

125,000

0

988

0

4,000

-

-

-

-

-

-

-

-

Asset acquisition, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

828,676

0

0

0

0

0

0

624,282

-81,751

-

-

-

-

Proceeds from sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

66,164

15,082

-

-

-

-

Proceeds from maturities of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

14,150

17,838

-

-

-

-

Acquisition of intangible assets

13,000

0

55,000

25,500

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,300

0

0

0

0

-3,375

1,125

1,125

1,125

Acquisition of investments

185,000

331,125

225,000

245,975

115,000

244,665

415,900

265,350

240,000

95,000

170,000

60,000

60,000

56,277

22,420

52,711

773

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net proceeds from sale of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,000

32,703

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

6,815

30,628

-

-

-

-

Purchase of product rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,750

1,250

8,250

1,250

-

-

-

-

Net cash (used in) provided by investing activities

-60,080

-159,053

-159,661

-2,638

166,052

39,992

-191,746

-190,584

-52,149

-31,878

-203,347

-30,151

-3,574

-1,859

-1,531,034

-206,267

-11,995

-3,367

-5,159

-12,022

18,293

-14,174

-83,139

-13,133

-957,203

-3,102

-3,152

-3,567

-6,443

87,189

-3,749

-561,242

82,508

-65,599

-13,622

-820

-1,191

Financing activities
Proceeds from employee equity incentive and purchase plans

13,264

31,741

9,968

13,065

3,057

9,281

16,998

56,470

10,588

9,031

3,722

13,395

5,676

6,223

3,340

10,831

3,780

6,498

7,295

13,226

13,504

10,035

16,810

10,175

21,467

7,126

8,114

5,854

9,609

4,008

2,422

13,413

5,160

-

-

-

-

Payment of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

35,100

0

0

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,526

Payment of employee withholding taxes related to share-based awards

13,547

839

1,087

1,003

13,810

733

1,169

1,429

14,594

680

1,589

1,889

14,431

639

6,317

1,802

12,476

700

8,723

1,901

14,778

724

6,755

1,188

9,363

287

3,706

170

1,427

0

0

0

25,299

-

-

-

-

Repayments of long-term debt

8,347

8,347

8,347

8,346

8,347

8,347

8,347

0

9,023

9,024

9,023

9,024

9,023

9,022

0

9,885

9,397

9,397

961

893,118

2,284

2,434

2,286

2,505

2,299

1,393

1,393

457,186

5,938

5,937

5,938

0

0

0

33,336

4,166

4,166

Share repurchases

139,053

110,335

19,997

59,869

111,249

446,657

21,454

21,015

34,546

42,374

25,566

16,963

13,896

18,477

96,575

28,879

134,365

40,251

9,612

1,352

10,338

12,242

6,486

23,487

0

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of Lines of Credit

-

-

-

-

-

-

-

-

-

0

500,000

200,000

150,000

150,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-4,000

0

-3,350

Net proceeds from issuance of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-981

559,011

0

636,355

0

0

553,425

0

-

-

-

-

-

-

-

-

Excess tax benefit from share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-320

-10,635

10,635

-

3,283

-4,985

5,777

-82

82

-889

889

5,519

-1,972

4,324

1,914

-

-

-

-

Acquisition of noncontrolling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19

310

17,465

119,175

0

0

0

0

-

-

-

-

-

-

-

-

Net cash used in financing activities

-147,683

-87,780

-19,463

-56,153

-130,349

-446,456

-13,972

28,873

-47,575

-39,984

27,028

-214,481

-181,674

-172,045

895,225

-29,735

-152,458

-123,861

-94,424

7,223

-3,261

-10,440

263,267

-39,455

497,662

-28,723

-45,722

47,456

3,133

3,590

-5,488

468,653

-18,225

2,801

-33,612

719

-2,990

Effect of exchange rates on cash and cash equivalents

-948

1,204

-943

217

-112

-1,028

-1,820

1,649

-501

723

824

1,759

1,740

-7,395

1,382

-2,826

3,794

-2,587

1,723

3,268

-13,026

-646

-3,040

45

188

833

2,241

1,188

-3,265

2,279

344

-491

0

-

-

-

-

Net increase in cash and cash equivalents

64,258

-157,831

157,436

90,273

237,844

-189,396

13,937

31,912

67,134

133,420

13,402

-107,782

-18,968

-604

-501,399

-111,814

-9,005

-10,074

77,216

139,040

98,561

109,002

306,785

22,381

-390,630

48,042

84,155

53,796

63,315

197,403

35,250

-16,111

88,578

-19,139

-1,181

37,335

20,267